13 min

The Landmark Series: Neoadjuvant Endocrine Therapy for Breast Cancer Speaking of SurgOnc

    • Natural Sciences

Rick Green, MD and Dr. Anna Weiss, MD discuss clinical trials that have defined the role of neoadjuvant endocrine therapy in patients with estrogen receptor-positive breast cancer. Dr. Weiss is author of “The Landmark Series: Neoadjuvant Endocrine Therapy for Breast Cancer.”

Dr. Weiss is Assistant Professor of Surgery at Harvard Medical School, Boston, MA.

Rick Green, MD and Dr. Anna Weiss, MD discuss clinical trials that have defined the role of neoadjuvant endocrine therapy in patients with estrogen receptor-positive breast cancer. Dr. Weiss is author of “The Landmark Series: Neoadjuvant Endocrine Therapy for Breast Cancer.”

Dr. Weiss is Assistant Professor of Surgery at Harvard Medical School, Boston, MA.

13 min